Literature DB >> 9438021

Flavonoid derivatives as adenosine receptor antagonists: a comparison of the hypothetical receptor binding site based on a comparative molecular field analysis model.

S Moro1, A M van Rhee, L H Sanders, K A Jacobson.   

Abstract

Flavonoid derivatives have been optimized as relatively rigid antagonists of adenosine receptors with particular selectivity for the A3 receptor subtype. A quantitative study of the structure-activity relationships for binding of flavonoids to adenosine A1, A2A, and A3 receptors has been conducted using comparative molecular field analysis (CoMFA). Correlation coefficients (cross-validated r2) of 0.605, 0.595, and 0.583 were obtained for the three subtypes, respectively. All three CoMFA models have the same steric and electrostatic contributions, implying similar requirements inside the binding cavity. Similarities were seen in the topology of steric and electrostatic regions with the A1 and A3 receptors, but not the A2A. Substitutions on the phenyl ring at the C-2 position of the chromone moiety may be considered important for binding affinity at all adenosine receptors. In the A3 model a region of favorable bulk interaction is located around the 2'-position of the phenyl ring. The presence of a C-6 substituent in the chromone moiety is well tolerated and increases the A1/A3 selectivity. The CoMFA coefficient contour plots provide a self-consistent picture of the main chemical features responsible for the pKi variations and also result in predictions which agree with experimental values.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9438021     DOI: 10.1021/jm970446z

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Ligand and structure-based methodologies for the prediction of the activity of G protein-coupled receptor ligands.

Authors:  Stefano Costanzi; Irina G Tikhonova; T Kendall Harden; Kenneth A Jacobson
Journal:  J Comput Aided Mol Des       Date:  2008-05-16       Impact factor: 3.686

2.  Multidimensional chemobehavior analysis of flavonoids and neuroactive compounds in zebrafish.

Authors:  Sean M Bugel; Robert L Tanguay
Journal:  Toxicol Appl Pharmacol       Date:  2018-02-27       Impact factor: 4.219

3.  In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson's Disease.

Authors:  Agostinho Lemos; Rita Melo; Antonio Jose Preto; Jose Guilherme Almeida; Irina Sousa Moreira; Maria Natalia Dias Soeiro Cordeiro
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

4.  Evaluation of the Diuretic Activity of the Aqueous and 80% Methanol Extracts of Ficus sur Forssk (Moraceae) Leaves in Saline-loaded Rats.

Authors:  Mesfin Ayele; Eyasu Makonnen; Akeberegn Gorems Ayele; Yosef Tolcha
Journal:  J Exp Pharmacol       Date:  2020-12-16

Review 5.  Progress in the pursuit of therapeutic adenosine receptor antagonists.

Authors:  Stefano Moro; Zhan-Guo Gao; Kenneth A Jacobson; Giampiero Spalluto
Journal:  Med Res Rev       Date:  2006-03       Impact factor: 12.388

6.  Central-stimulating and analgesic activity of the ethanolic extract of Alternanthera sessilis in mice.

Authors:  Himangsu Mondal; Sanjib Saha; Khalijah Awang; Hemayet Hossain; Abdulwali Ablat; Md Khirul Islam; Ismet Ara Jahan; Samir K Sadhu; Md Golam Hossain; Jamil A Shilpi; Shaikh J Uddin
Journal:  BMC Complement Altern Med       Date:  2014-10-15       Impact factor: 3.659

Review 7.  Interactions of flavones and other phytochemicals with adenosine receptors.

Authors:  Kenneth A Jacobson; Stefano Moro; John A Manthey; Patrick L West; Xiao-Duo Ji
Journal:  Adv Exp Med Biol       Date:  2002       Impact factor: 2.622

Review 8.  Exploration of chalcones and related heterocycle compounds as ligands of adenosine receptors: therapeutics development.

Authors:  Chrisna Matthee; Gisella Terre'Blanche; Lesetja J Legoabe; Helena D Janse van Rensburg
Journal:  Mol Divers       Date:  2021-06-27       Impact factor: 3.364

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.